The market is benefiting from the growing complexity of global clinical trials, increasing approval of novel therapeutics, rising demand for real-world evidence, and advancements in digital safety monitoring technologies. Pharmaceutical companies are increasingly outsourcing pharmacovigilance functions to enhance scalability, reduce operational costs, and ensure compliance with evolving regulatory standards worldwide.